Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapyJohn M L Ebos, Christina R Lee, Robert S Kerbel
Frontiers in Immunology|July 25, 2022
Thymus Reconstitution in Young and Aged Mice Is Facilitated by In Vitro-Generated Progenitor T CellsMahmood Mohtashami, Yue Ru Li, Christina R Lee, et al.
Cancer Research|April 25, 2015
Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular CarcinomaElizabeth A Kuczynski, Christina R Lee, Shan Man, et al.
Neoplasia (New York, N.Y.)|March 18, 2010
Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinomaTerence C Tang, Shan Man, Christina R Lee, et al.
Journal of Visualized Experiments : Jove|May 20, 2014
Modeling spontaneous metastatic renal cell carcinoma (mRCC) in mice following nephrectomyAmanda Tracz, Michalis Mastri, Christina R Lee, et al.
Plos One|August 23, 2013
Differential post-surgical metastasis and survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) mice with parental and subline variants of human breast cancer: implications for host defense mechanisms regulating metastasisChloe C Milsom, Christina R Lee, Christina Hackl, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2007
Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacyJohn M L Ebos, Christina R Lee, James G Christensen, et al.
EMBO Molecular Medicine|April 9, 2015
Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2Florence T H Wu, Christina R Lee, Elena Bogdanovic, et al.
Cancer Research|April 6, 2006
Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapyRaquel Munoz, Shan Man, Yuval Shaked, et al.
Anticancer Research|August 5, 2003
Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemiaChristina R Lee, Dave Cervi, Amandine H Truong, et al.
Pageof 4